+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free

Global Immunoassay Instruments Market to be Driven by Growing Preference for Personalized Medicine

Posted on Jan 29, 2016

A new research report has been recently published by Transparency Market research and is available for sale on the company website. The research report, titled “Immunoassay Instruments Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020”, provides detailed analysis of the global immunoassay instruments market.According to the research study, in 2013, the global market for immunoassay instruments market was worth US$13.5 bn and is anticipated to reach US$23.3 bn by the end of 2020, exhibiting a progressive 8.10% CAGR between 2014 and 2020.

Browse the full Immunoassay Instruments Market (Product: Chemiluminescence (CLI), Immunofluorescence (IFA) & Radioimmunoassay (RIA) Analyzers, Enzyme Linked Fluorescence (ELFA) & Multiplexed Assay Systems, Enzyme Immunoassay Instruments; Application: Oncology, Endocrinology, Infectious Diseases, Therapeutic Drug Monitoring, Cardiology, Autoimmune Disorders & Drugs of Abuse) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020 report at http://www.transparencymarketresearch.com/immunoassay-instruments-market.html

The growing prevalence of chronic diseases is the main factor driving the global immunoassay instruments market. In addition, the increasing rate of HIV infections, growing preference for personalized medicine, and technological advancements in immunoassay instruments are propelling the global market. However, the high costs linked with technical advancements is the restraining factor acting upon the global immunoassay instruments market.

By type, the global market for immunoassay instruments has been segmented into radioimmunoassay analyzers, multiplexed assay systems, enzyme immunoassay instruments, chemiluminescence analyzers, immuno fluorescence analyzers, and enzyme-linked fluorescent systems. In 2013, the chemiluminescence analyzers segment held a share of 27% in the overall market owing to the high accuracy and sensitivity displayed by chemiluminescence analyzers in detection of analytes. This segment is estimated to remain dominant throughout the forecast period. On the other hand, the enzyme-linked fluorescent systems and immuno fluorescence analyzers segments are also expected to witness significant growth in the next few years. By application, the global market for immunoassay instruments has been classified into oncology, drugs of abuse, endocrinology, autoimmune diseases, therapeutic drug monitoring, infectious diseases, and cardiology.

By geography, the global market for immunoassay instruments has been divided into North America, Asia Pacific, Europe, and Rest of the World. In 2013, North America held the biggest share in the overall market owing to the high rate of adoption of novel immunoassay procedures in this region. Moreover, the rising incidence of obesity and several types of disorders such as cardiac and endocrine is expected to boost the demand from the immunoassay instruments market in the forecast period. As per statistics provided by the World Health Organization (WHO), at present, around 347 million people across the globe are suffering from diabetes and by the end of 2030, diabetes will be the seventh leading cause of death worldwide.

In Asia Pacific and Rest of the World, the growth of the immunoassay instruments market is significantly low when compared to developed nations such as the U. S., France, and Germany, owing to the low affordability and lack of accessibility. Nevertheless, the use of immunoassay instruments is projected to increase in the forecast period thanks to the growing healthcare expenditure and developing healthcare infrastructure in countries such as China, India, and Brazil.

The research report further covers the competitive landscape of the global immunoassay instruments market based on specific parameters. Some of the prominent players mentioned in this report are Sysmex Corporation, Siemens Healthcare, Merck Millipore, Thermo Fisher Scientific, Beckman Coulter, Inc., DiaSorin S.p.A, Abbott Laboratories, bioMerieux, Inc., Ortho Clinical Diagnostics, and F. Hoffman-La Roche, Ltd.

Key Segments of the Immunoassay Instruments Market:

Immunoassay Instruments Market, by Product Type

  • Chemiluminescence (CLI) Analyzers
  • Immuno Fluorescence (IFA) Analyzers
  • Enzyme Immunoassay Instruments
  • Radioimmunoassay Analyzers
  • Enzyme Linked Fluorescent Systems
  • Multiplexed Assay Systems

Immunoassay Instruments Market, by Application

  • Endocrinology
  • Oncology
  • Infectious Diseases
  • Cardiology
  • Therapeutic Drug Monitoring
  • Autoimmune Diseases
  • Drugs of Abuse

Immunoassay Instruments Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Browse : Our new press releases http://www.transparencymarketresearch.com/pressrelease/global-immunoassay-instruments-market.htm

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact

Mr.Sudip S
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

Back To Top